Contineum Therapeutics CTNM
NASDAQ CTNM
$10.77 +0.21 (+1.99%)
At close: Nov 11, 2026 · 4:00 PM EST

Contineum Therapeutics (CTNM) Depreciation & Amortization (CF) (2023 - 2026)

Updated

Contineum Therapeutics' Depreciation & Amortization (CF) was $81,000 in Q3 2026, unchanged from $81,000 a year earlier and down 39.6% from the prior quarter.

Analysis

Contineum Therapeutics (CTNM) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends

On a trailing twelve-month basis, Contineum Therapeutics' Depreciation & Amortization (CF) was $383,000 through Sep 30, 2026, up 7.9% year-over-year; for FY2025, it was $323,000, up 7.7% from FY2024.

  • In earlier years, Depreciation & Amortization (CF) was $300,000 in FY2024 (+50.0%) and $200,000 in FY2023.
  • Quarterly Depreciation & Amortization (CF) has moved between $42,000 (Q2 2023) and $134,000 (Q2 2026) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) was higher in six of the last eight quarters, with growth averaging 39.7%.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q4 2024 (growth of 178.6%); the worst was Q4 2025 (a decline of 27.4%).
  • Per Business Quant data, CTNM's Depreciation & Amortization (CF) in the three quarters before Q3 2026 was $134,000 (Q2 2026), $83,000 (Q1 2026) and $85,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 Contineum Therapeutics 405.40 Mn -584.86 Mn - 81,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 81,000.00
Jun 30, 2026 134,000.00
Mar 31, 2026 83,000.00
Dec 31, 2025 85,000.00
Sep 30, 2025 81,000.00
Jun 30, 2025 79,000.00
Mar 31, 2025 78,000.00
Dec 31, 2024 117,000.00
Sep 30, 2024 62,000.00
Jun 30, 2024 60,000.00
Mar 31, 2024 61,000.00
Dec 31, 2023 42,000.00
Sep 30, 2023 43,000.00
Jun 30, 2023 42,000.00
Mar 31, 2023 73,000.00
API Access

Contineum Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CTNM&period=max&api_key=YOUR_API_KEY